Kévin Alexandre

878 total citations
23 papers, 316 citations indexed

About

Kévin Alexandre is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Kévin Alexandre has authored 23 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Molecular Medicine and 6 papers in Pharmacology. Recurrent topics in Kévin Alexandre's work include Antibiotic Resistance in Bacteria (11 papers), Urinary Tract Infections Management (9 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Kévin Alexandre is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Urinary Tract Infections Management (9 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Kévin Alexandre collaborates with scholars based in France and Martinique. Kévin Alexandre's co-authors include Manuel Etienne, B. Fantin, François Caron, Martine Pestel‐Caron, David Debeaumont, Tristan Bonnevie, Eglantine Ferrand Devouge, Pauline Smondack, Fairuz Boujibar and A. Cuvelier and has published in prestigious journals such as Scientific Reports, Clinical Chemistry and Frontiers in Microbiology.

In The Last Decade

Kévin Alexandre

19 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kévin Alexandre France 10 108 81 68 67 61 23 316
Arta Karruli Italy 9 106 1.0× 38 0.5× 60 0.9× 68 1.0× 109 1.8× 18 284
Joana Alves Portugal 8 83 0.8× 49 0.6× 32 0.5× 72 1.1× 74 1.2× 34 278
Inmaculada López-Montesinos Spain 10 110 1.0× 40 0.5× 60 0.9× 92 1.4× 98 1.6× 25 345
О Н Ершова Russia 12 249 2.3× 105 1.3× 42 0.6× 89 1.3× 33 0.5× 39 468
María Ruiz‐Ruigómez Spain 11 51 0.5× 37 0.5× 36 0.5× 119 1.8× 127 2.1× 30 331
Patrizia Murino Italy 9 349 3.2× 43 0.5× 241 3.5× 206 3.1× 101 1.7× 13 565
Suyun Qian China 13 20 0.2× 91 1.1× 22 0.3× 145 2.2× 156 2.6× 49 453
Aydın Deveci Türkiye 9 48 0.4× 37 0.5× 26 0.4× 76 1.1× 79 1.3× 32 218
Erica Bacca Italy 6 76 0.7× 51 0.6× 41 0.6× 48 0.7× 94 1.5× 10 266
Paolo Cattaneo Italy 9 69 0.6× 18 0.2× 46 0.7× 60 0.9× 31 0.5× 33 254

Countries citing papers authored by Kévin Alexandre

Since Specialization
Citations

This map shows the geographic impact of Kévin Alexandre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kévin Alexandre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kévin Alexandre more than expected).

Fields of papers citing papers by Kévin Alexandre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kévin Alexandre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kévin Alexandre. The network helps show where Kévin Alexandre may publish in the future.

Co-authorship network of co-authors of Kévin Alexandre

This figure shows the co-authorship network connecting the top 25 collaborators of Kévin Alexandre. A scholar is included among the top collaborators of Kévin Alexandre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kévin Alexandre. Kévin Alexandre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alexandre, Kévin, Anaïs R. Briant, François Caron, et al.. (2025). Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study. Journal of Antimicrobial Chemotherapy. 80(12). 3329–3334.
3.
Alexandre, Kévin, et al.. (2025). Linezolid use in post-neurosurgical central nervous system infections: A systematic review. Neurosurgical Review. 48(1). 714–714.
4.
Leoz, Marie, et al.. (2024). Are Escherichia coli causing recurrent cystitis just ordinary uropathogenic E. coli (UPEC) strains?. Virulence. 16(1). 2444689–2444689.
5.
6.
Etienne, Manuel, et al.. (2023). Short-Course Versus Prolonged-Course Antimicrobial Therapy in Adults With Catheter-Related Septic Thrombosis: A Propensity-Weighted Retrospective Study. Open Forum Infectious Diseases. 10(11). ofad530–ofad530. 3 indexed citations
7.
Alexandre, Kévin, et al.. (2022). Phenotypic and genotypic within-host diversity of Pseudomonas aeruginosa urinary isolates. Scientific Reports. 12(1). 5421–5421. 9 indexed citations
8.
Fares, Youssef, Paul Billoir, Ann Van Den Bogaert, et al.. (2021). Systematic screening for a proximal DVT in COVID-19 hospitalized patients: Results of a comparative study. JMV-Journal de Médecine Vasculaire. 46(4). 163–170. 6 indexed citations
9.
Debeaumont, David, Fairuz Boujibar, Eglantine Ferrand Devouge, et al.. (2021). Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalisation – A pilot study. PA3164–PA3164. 1 indexed citations
10.
Billoir, Paul, Kévin Alexandre, Thomas Duflot, et al.. (2021). Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection. Frontiers in Medicine. 8. 670694–670694. 17 indexed citations
11.
Debeaumont, David, Fairuz Boujibar, Eglantine Ferrand Devouge, et al.. (2021). Cardiopulmonary Exercise Testing to Assess Persistent Symptoms at 6 Months in People With COVID-19 Who Survived Hospitalization: A Pilot Study. Physical Therapy. 101(6). 63 indexed citations
12.
Cassinari, Kévin, Élodie Alessandri-Gradt, Pascal Chambon, et al.. (2020). Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples. Clinical Chemistry. 67(5). 736–741. 30 indexed citations
13.
Alexandre, Kévin, et al.. (2020). Cellulitis and bacteremia after a snake bite despite antibiotic preemptive treatment: A diagnosis challenge. Travel Medicine and Infectious Disease. 35. 101555–101555. 1 indexed citations
14.
15.
Alexandre, Kévin, et al.. (2020). Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 76(3). 784–788. 12 indexed citations
16.
Alexandre, Kévin, et al.. (2018). Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates. Journal of Antimicrobial Chemotherapy. 74(5). 1323–1326. 5 indexed citations
17.
Alexandre, Kévin, S. Oro, Mathilde Versini, L. Sailler, & Y. Benhamou. (2017). Pneumocystis jirovecii pneumonia in patients treated with rituximab for systemic diseases: Report of 11 cases and review of the literature. European Journal of Internal Medicine. 50. e23–e24. 12 indexed citations
18.
Alexandre, Kévin & B. Fantin. (2017). Pharmacokinetics and Pharmacodynamics of Temocillin. Clinical Pharmacokinetics. 57(3). 287–296. 40 indexed citations
19.
Alexandre, Kévin, F. Chau, François Guérin, et al.. (2016). Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producingEscherichia coli. Journal of Antimicrobial Chemotherapy. 71(7). 1899–1904. 22 indexed citations
20.
Caron, François, Kévin Alexandre, Martine Pestel‐Caron, et al.. (2015). High bacterial titers in urine are predictive of abnormal postvoid residual urine in patients with urinary tract infection. Diagnostic Microbiology and Infectious Disease. 83(1). 63–67. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arta Karruli Breakdown of academic impact, for papers by Joana Alves Breakdown of academic impact, for papers by Inmaculada López-Montesinos Breakdown of academic impact, for papers by О Н Ершова Breakdown of academic impact, for papers by María Ruiz‐Ruigómez Breakdown of academic impact, for papers by Patrizia Murino Breakdown of academic impact, for papers by Suyun Qian Breakdown of academic impact, for papers by Aydın Deveci Breakdown of academic impact, for papers by Erica Bacca Breakdown of academic impact, for papers by Paolo Cattaneo
Rankless by CCL
2026